{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=22220&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=22180&ordering=-accession","results":[{"accession":"CLO:0020808","name":"ND08061 cell","definition":"[\" DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS POPULATION/CONVENIENCE CONTROL\"]","term_type":"cell line"},{"accession":"CLO:0020807","name":"ND08060 cell","definition":"[\" DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS POPULATION/CONVENIENCE CONTROL\"]","term_type":"cell line"},{"accession":"CLO:0020806","name":"ND08020 cell","definition":"[\" POPULATION/CONVENIENCE CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS\"]","term_type":"cell line"},{"accession":"CLO:0020805","name":"ND08024 cell","definition":"[' ISCHEMIC STROKE NDPT080 ISCHEMIC STROKE DNA PANEL']","term_type":"cell line"},{"accession":"CLO:0020804","name":"ND08023 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0020803","name":"ND08022 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0020802","name":"ND08021 cell","definition":"[' EPILEPSY']","term_type":"cell line"},{"accession":"CLO:0020801","name":"ND08028 cell","definition":"[' ISCHEMIC STROKE NDPT080 ISCHEMIC STROKE DNA PANEL']","term_type":"cell line"},{"accession":"CLO:0020800","name":"ND08027 cell","definition":"[' POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0020799","name":"ND08026 cell","definition":"[' ISCHEMIC STROKE']","term_type":"cell line"},{"accession":"CLO:0020798","name":"ND08025 cell","definition":"[\" POPULATION/CONVENIENCE CONTROL DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS\"]","term_type":"cell line"},{"accession":"CLO:0020797","name":"ND08029 cell","definition":"[' POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0020796","name":"GM11411 cell","definition":"[' ADENOSINE DEAMINASE; ADA SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0020795","name":"GM11412 cell","definition":"[' SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY ADENOSINE DEAMINASE; ADA']","term_type":"cell line"},{"accession":"CLO:0020794","name":"GM11413 cell","definition":"[' SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY ADENOSINE DEAMINASE; ADA']","term_type":"cell line"},{"accession":"CLO:0020793","name":"GM11416 cell","definition":"[' GLYCOGEN STORAGE DISEASE I']","term_type":"cell line"},{"accession":"CLO:0020792","name":"GM11418 cell","definition":"[' NIGMS MAPPING PANEL #2, VERSION 3, HUMAN/RODENT SOMATIC CELL HYBRIDS']","term_type":"cell line"},{"accession":"CLO:0020791","name":"GM11406 cell","definition":"[' WEAVER SYNDROME']","term_type":"cell line"},{"accession":"CLO:0020790","name":"GM11407 cell","definition":"[' WEAVER SYNDROME']","term_type":"cell line"},{"accession":"CLO:0020789","name":"GM11408 cell","definition":"[' ACYL-CoA DEHYDROGENASE, LONG-CHAIN, DEFICIENCY OF']","term_type":"cell line"}]}